Intellia Therapeutics
NTLA
11.71
-0.66
-5.34%
Intellia Therapeutics
US · NTLA
#2899 by market cap
Listed 2016
11.71
-0.66
-5.34%
Live - 5344 symbols - heartbeat 225s ago
· 2026-10-08 07:34
Pre-market
11.67
-0.34%
After-hours
11.81
+0.85%
Overnight
11.68
-0.26%
- Market cap
- 1.64B
- P/E (TTM)i
- -3.51
- P/Bi
- 2.25
- EPSi
- -3.81
- Div yieldi
- 0.00%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on NTLA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Buy
Avg price target
20.50 +75.1%
Price target rangecurrent 11.71
Low9.00
Avg20.50
High49.00
Buy 50%
Hold 33%
Sell 17%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-09 | Wedbush | -- | HOLD | 13.00 |
| 2026-09-09 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-09-04 | TD Cowen | -- | BUY | -- |
| 2026-08-14 | JonesTrading | -- | BUY | 29.00 |
| 2026-08-10 | Morgan Stanley | -- | HOLD | 15.00 |
| 2026-08-07 | BofA Securities | -- | HOLD | 17.00 |
| 2026-08-07 | Evercore | -- | BUY | 24.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-08-06 | CCORF | -- | BUY | 49.00 |
| 2026-08-06 | William Blair | -- | BUY | -- |
| 2026-08-06 | Evercore | -- | BUY | 24.00 |
| 2026-08-06 | Goldman Sachs | -- | SELL | 9.00 |
| 2026-08-06 | RBC Capital | -- | HOLD | 15.00 |
| 2026-07-15 | Wolfe Research | -- | SELL | 9.00 |
| 2026-06-16 | CCORF | -- | BUY | 49.00 |
| 2026-06-15 | William Blair | -- | BUY | -- |
| 2026-06-15 | BofA Securities | -- | HOLD | 19.00 |
| 2026-06-15 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-06-14 | TD Cowen | -- | BUY | -- |
| 2026-06-14 | Goldman Sachs | -- | SELL | 9.00 |
| 2026-05-27 | JonesTrading | -- | BUY | 29.00 |
| 2026-05-13 | Morgan Stanley | -- | HOLD | 15.00 |
| 2026-05-13 | H.C. Wainwright | -- | BUY | 25.00 |
| 2026-05-13 | J.P. Morgan | -- | SELL | 8.00 |
| 2026-05-12 | CCORF | -- | BUY | 49.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
3 5
■ Upgrades■ Downgrades
- 3 upgrades vs 5 downgrades among tracked analyst rating changes.
- The single most recent change was actually an upgrade (Evercore moved from Hold to Buy on 2026-08-06), though the broader window skews toward downgrades.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-06 | Evercore | HOLD → BUY | 24.00 |
| 2026-07-15 | Wolfe Research | HOLD → SELL | 9.00 |
| 2026-04-28 | Evercore | BUY → HOLD | 16.00 |
| 2026-03-04 | JonesTrading | HOLD → BUY | 29.00 |
| 2026-03-02 | William Blair | HOLD → BUY | -- |
| 2025-11-11 | JonesTrading | BUY → HOLD | -- |
| 2025-11-07 | J.P. Morgan | HOLD → SELL | 5.00 |
| 2025-10-31 | BofA Securities | BUY → HOLD | 14.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±11.82% | +2.46% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±17.42% | +6.41% (in line) |
| 2025/Q2 | 2025-08-07 | -- | ±20.15% | +0.79% (in line) |
| 2025/Q1 | 2025-05-08 | -- | ±21.04% | +13.58% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±23.48% | +0.56% (in line) |
| 2024/Q3 | 2024-11-07 | -- | ±13.59% | -0.37% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±19.43% | +5.02% (in line) |
| 2024/Q1 | 2024-05-09 | -- | ±15.08% | +8.09% (in line) |
| 2023/Q4 | 2024-02-22 | -- | ±19.29% | +1.12% (in line) |
| 2023/Q3 | 2023-11-09 | -- | ±13.81% | -12.27% (in line) |
| 2023/Q2 | 2023-08-03 | -- | ±15.20% | -1.56% (in line) |
| 2023/Q1 | 2023-05-04 | -- | ±15.25% | +13.14% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:34:37 · For reference only, not investment advice and not tailored to your situation.